Phoenix Nest and LA BioMed Receive Over $1.7 million to Develop Treatments for Devastating Childhood Disease

Phoenix Nest Inc and LA BioMed Logos

The National Institute of Neurological Disorders and Stroke recently awarded over $1.7 million in grant funding to Phoenix Nest, Inc. to continue its partnership with the Los Angeles Biomedical Institute (LA BioMed) to research the development of therapies for treating different forms of a devastating inherited genetic disorder, Sanfilippo disease, also known as MPS III.

Sodium Bicarbonate Treatments Could Prevent Deadly Fungal Infections In Patients with Diabetic Ketoacidosis

Ibrahim Ashraf
New Study Identifies Processes Leading to Mucormycosis Infections

Patients with diabetic ketoacidosis (DKA) face a much higher risk of succumbing to a deadly fungal infection, known as mucormycosis, than healthy patients. A new study suggests a simple treatment of sodium bicarbonate, or baking soda, could prevent the spread of mucormycosis in patients with DKA.